Correlation Between GlaxoSmithKline PLC and Angkor Resources
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Angkor Resources at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Angkor Resources into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Angkor Resources Corp, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Angkor Resources and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Angkor Resources. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Angkor Resources.
Diversification Opportunities for GlaxoSmithKline PLC and Angkor Resources
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between GlaxoSmithKline and Angkor is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Angkor Resources Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Angkor Resources Corp and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Angkor Resources. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Angkor Resources Corp has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Angkor Resources go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Angkor Resources
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Angkor Resources. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 6.05 times less risky than Angkor Resources. The stock trades about -0.23 of its potential returns per unit of risk. The Angkor Resources Corp is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 9.00 in Angkor Resources Corp on August 31, 2024 and sell it today you would earn a total of 0.50 from holding Angkor Resources Corp or generate 5.56% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Angkor Resources Corp
Performance |
Timeline |
GlaxoSmithKline PLC ADR |
Angkor Resources Corp |
GlaxoSmithKline PLC and Angkor Resources Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GlaxoSmithKline PLC and Angkor Resources
The main advantage of trading using opposite GlaxoSmithKline PLC and Angkor Resources positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Angkor Resources can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Angkor Resources will offset losses from the drop in Angkor Resources' long position.GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
Angkor Resources vs. Solar Alliance Energy | Angkor Resources vs. Global X Active | Angkor Resources vs. Financial 15 Split | Angkor Resources vs. Rubicon Organics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Stocks Directory Find actively traded stocks across global markets |